Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-12.81%Return on Equity
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 43.59M | $ -5.59M | -12.81% |
| 3/31/2025 | $ 51.89M | $ 23.36M | 45.02% |
| 12/31/2024 | $ 40.25M | $ 12.04M | 29.92% |
| 9/30/2024 | $ 43.45M | $ 9.47M | 21.79% |
| 6/30/2024 | $ 47.71M | $ 10.17M | 21.31% |
| 3/31/2024 | $ 27.65M | $ -17.24M | -62.35% |
| 12/31/2023 | $ 31.37M | $ -11.51M | -36.68% |
| 9/30/2023 | $ 36.77M | $ -6.65M | -18.09% |
| 6/30/2023 | $ 42.73M | $ -6.27M | -14.68% |
| 3/31/2023 | $ 72.69M | $ -4.32M | -5.94% |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) ROE stands at -41.8%.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average ROE has been -13.43%.
- The median ROE for PHARMACYTE BIOTECH INC during this period was -7.13%
- PHARMACYTE BIOTECH INC reached its highest ROE over the past 5 years at 45.02%.
- The lowest ROE recorded by PHARMACYTE BIOTECH INC in the same timeframe -64.64%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for PHARMACYTE BIOTECH INC is calculated as follows: Net Inc. Cmn. [ $ -3.46M ] / Equity [ $ 8.28M ]
(=) ROE [ -41.8% ] PMCB - Return on Equity, Last 5 years
-64.64%
Minimum
Jun 30, 2021
45.02%
Maximum
Mar 31, 2025
-13.43%
Average
-7.13%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |